The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3,4,5-trimethoxyphenylamino)quinoline-7-carbonitrile ID: ALA4575895
PubChem CID: 155563824
Max Phase: Preclinical
Molecular Formula: C19H17N3O3
Molecular Weight: 335.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(Nc2ccnc3cc(C#N)ccc23)cc(OC)c1OC
Standard InChI: InChI=1S/C19H17N3O3/c1-23-17-9-13(10-18(24-2)19(17)25-3)22-15-6-7-21-16-8-12(11-20)4-5-14(15)16/h4-10H,1-3H3,(H,21,22)
Standard InChI Key: BLWQIEISIMYCHD-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
5.4142 -18.8491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4131 -18.0267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7050 -17.6202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9934 -18.0310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9985 -18.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7112 -19.2634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7031 -16.7989 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2799 -17.6254 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2893 -19.2738 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5748 -18.8656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2764 -16.8041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4098 -16.3845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1272 -19.2598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1296 -20.0811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4181 -20.4883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4202 -21.3088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1338 -21.7203 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8412 -20.4819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8445 -21.2988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5531 -21.7047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2588 -21.2907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2516 -20.4706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5424 -20.0726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9735 -21.6964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6882 -22.1000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
4 8 1 0
5 9 1 0
9 10 1 0
8 11 1 0
7 12 1 0
1 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 19 1 0
18 14 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 18 2 0
24 25 3 0
21 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 335.36Molecular Weight (Monoisotopic): 335.1270AlogP: 3.88#Rotatable Bonds: 5Polar Surface Area: 76.40Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.01CX LogP: 2.95CX LogD: 2.95Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.76Np Likeness Score: -0.94
References 1. Asquith CRM, Berger BT, Wan J, Bennett JM, Capuzzi SJ, Crona DJ, Drewry DH, East MP, Elkins JM, Fedorov O, Godoi PH, Hunter DM, Knapp S, Müller S, Torrice CD, Wells CI, Earp HS, Willson TM, Zuercher WJ.. (2019) SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK)., 62 (5): [PMID:30768268 ] [10.1021/acs.jmedchem.8b01213 ] 2. Asquith CRM,Treiber DK,Zuercher WJ. (2019) Utilizing comprehensive and mini-kinome panels to optimize the selectivity of quinoline inhibitors for cyclin G associated kinase (GAK)., 29 (14.0): [PMID:31129055 ] [10.1016/j.bmcl.2019.05.025 ] 3. Saul S,Pu SY,Zuercher WJ,Einav S,Asquith CRM. (2020) Potent antiviral activity of novel multi-substituted 4-anilinoquin(az)olines., 30 (16): [PMID:32631507 ] [10.1016/j.bmcl.2020.127284 ]